American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

Action · US0287315032 (OTC)
Aperçu
Analyse alimentée par l’IA
Analyse fondamentale
Découvrez ce que disent vraiment les chiffres — avant le marché
Analyser maintenant
Sentiment des actualités
Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?
Analyser maintenant
Acheter / Conserver / Vendre
Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.
Analyser maintenant
Évaluation des risques
Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.
Analyser maintenant
Juste valeur
Cette action est-elle bon marché, correctement valorisée ou surévaluée ?
Analyser maintenant
Dernières analyses d’IA sur American Oriental Bioengineering, Inc.
Pas de cours
Cours de clôture OTC 28.04.2026: 0,001 USD
28.04.2026 20:00
Cours actuels de American Oriental Bioengineering, Inc.
BourseTickerDeviseDernier échangeCoursVariation journalière
OTC: UTC
UTC
AOBI
USD
28.04.2026 20:00
0,001 USD
0,00 USD
Profil de l'entreprise pour American Oriental Bioengineering, Inc. Action
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

Données de l'entreprise

Nom American Oriental Bioengineering, Inc.
Société American Oriental Bioengineering, Inc.
Site web http://www.bioaobo.com
Marché d'origine OTC UTC
ISIN US0287315032
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Shujun Liu
Pays Chine
Devise USD
Employés 3,7 T
Adresse 1 First Liangshuihe Avenue, 100176 Beijing
Date d'introduction en bourse 2001-12-12

Fractionnements d'actions

Date Fractionnement
21.08.2014 1:501
03.04.2014 1:501
27.02.2012 1:2

Symboles boursiers

Nom Symbole
Over The Counter AOBI
Autres actions
Les investisseurs qui détiennent American Oriental Bioengineering, Inc. ont également les actions suivantes dans leur portefeuille :
DEKA-MEGATRENDS CF
DEKA-MEGATRENDS CF Fonds
iShares MSCI Europe IMI Index ETF (CAD-Hedged)
iShares MSCI Europe IMI Index ETF (CAD-Hedged) ETF